Anti-cGMP antibody [EPR10355]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
5
(1 Review)
|
(2 Publications)
Rabbit Recombinant Monoclonal Guanosine, cyclic 3',5'-(hydrogen phosphate), monosodium salt antibody. Suitable for cELISA and reacts with Chemical samples. Cited in 2 publications.
View Alternative Names
Cyclic GMP, Cyclic guanosine monophosphate, Guanosine 3 5 Cyclic Monophosphate, cGMP
- cELISA
Unknown
Competitive ELISA - Anti-cGMP antibody [EPR10355] (AB169753)
2 μg/ml of Goat anti-rabbit IgG (50 μl/well) was coated into 96-wells. After washing with 0.1 % Tween-20, 0.1 μg/ml of ab169753 (50 μl/well) was added and incubated for 1 hour. After washing, 0, 8, 48, 64, 96, 128, 256 and 1000 ng/ml of cAMP, AMP, ADP, ATP, cGMP, GMP, GDP, GTP, cIMP and cCMP (25 μl/well) were added along with 25 μl of the 1/50 diluted HRP conjugated cGMP. After washing, TMB was used to develop the color.
- cELISA
Unknown
Competitive ELISA - Anti-cGMP antibody [EPR10355] (AB169753)
2μg/ml of goat-anti-rabbit IgG (50μl/well) was coated into 96-wells. After washing with 0.1% Tween-20, 0.2μg/ml of ab169753 (50 μl / well) was added and incubated for 1hr. Then 62.5ng/ml of cAMP, AMP, ADP, ATP, cGMP, GMP, GDP, GTP, cIMP, cCMP and H2O (25 μl / well each) were added, respectively. Finally 25 μl of 1/50 diluted HRP conjugated cGMP was added in each well. TMB was used to develop the color.
Related conjugates and formulations (1)
-
Anti-cGMP antibody [EPR10355] - BSA and Azide free
Reactivity data
Product details
The product is specific for cGMP and as tested it does not cross-react with cAMP, AMP, ADP, ATP, cGMP, GMP, GDP, GTP and cCMP.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cyclic guanosine monophosphate influences vasodilation and neurotransmission. It functions within cellular signaling complexes and often partners with proteins such as protein kinases to achieve its biological effects. cGMP facilitates the relaxation of smooth muscle tissues impacting cardiovascular health by regulating blood vessel dilation. Similarly it modulates neural signaling affecting processes like memory formation and vision.
Pathways
CGMP plays an important role in the nitric oxide signaling pathway and the atrial natriuretic peptide (ANP) pathway. Within the nitric oxide signaling pathway cGMP works in coordination with nitric oxide synthase and protein kinase G to mediate vasodilation. In the ANP pathway cGMP acts downstream of guanylate cyclase-linked receptors in maintaining cardiovascular and renal functions interconnecting with proteins like atrial natriuretic peptide to regulate blood pressure and volume.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Communications medicine 5:384 PubMed40897815
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:344 PubMed36670126
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com